Pelago Bioscience is attending New Therapeutic Modalities: Transforming Receptor Pharmacology, hosted by the British Pharmacological Society, on April 2–3 in Cambridge, UK. This event will bring together experts to explore new approaches in receptor pharmacology and therapeutic discovery.
Mary Spanou (Regional Sales Manager) and Isabel Martin Caballero (Project Advisor) will represent Pelago Bioscience. They will be available to discuss how CETSA® technology supports drug discovery by providing biologically relevant insights into compound selectivity and target engagement.
Presentations at the Conference
Poster Presentation
“Enhancing PROTAC research: CETSA as a tool for assessing selectivity of warheads and PROTACs and evaluation of non-degraded targets”
Presenter: Isabel Martin Caballero
Poster #13
Date & Time: April 2–3, during lunch and refreshment intervals
Scientific Talk
“CETSA-based evaluation of non-degraded PROTAC targets. Assessing degraders binding and MoA in live cells”
Presenter: Isabel Martin Caballero
Date & Time: April 2, 3:30–3:50 PM
Let’s Connect
If you are attending and would like to discuss how Pelago Bioscience can support your research, schedule a meeting with our team:
For more information about the event, visit BPS New Therapeutic Modalities Conference.